Man Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.19M Buy
286,933
+90,615
+46% +$1.95M 0.01% 825
2025
Q1
$3.26M Sell
196,318
-1,024,704
-84% -$17M 0.01% 1017
2024
Q4
$22.4M Sell
1,221,022
-54,411
-4% -$998K 0.06% 336
2024
Q3
$19.6M Buy
1,275,433
+1,218,288
+2,132% +$18.7M 0.05% 424
2024
Q2
$929K Buy
57,145
+6,844
+14% +$111K ﹤0.01% 1402
2024
Q1
$930K Buy
50,301
+18,081
+56% +$334K ﹤0.01% 1457
2023
Q4
$1.01M Buy
+32,220
New +$1.01M ﹤0.01% 1337
2023
Q3
Sell
-277,196
Closed -$6.64M 1202
2023
Q2
$6.64M Buy
+277,196
New +$6.64M 0.02% 758
2023
Q1
Sell
-955,688
Closed -$15.2M 471
2022
Q4
$15.2M Buy
955,688
+932,503
+4,022% +$14.8M 0.05% 414
2022
Q3
$379K Buy
+23,185
New +$379K ﹤0.01% 1568
2022
Q2
Sell
-19,436
Closed -$470K 1979
2022
Q1
$470K Buy
+19,436
New +$470K ﹤0.01% 1575
2021
Q1
Sell
-50,129
Closed -$2.68M 1824
2020
Q4
$2.68M Sell
50,129
-9,131
-15% -$488K 0.01% 1086
2020
Q3
$2.44M Sell
59,260
-56,160
-49% -$2.32M 0.01% 1122
2020
Q2
$5.59M Buy
115,420
+65,835
+133% +$3.19M 0.03% 610
2020
Q1
$2.1M Sell
49,585
-37,732
-43% -$1.59M 0.01% 863
2019
Q4
$3.74M Buy
+87,317
New +$3.74M 0.01% 1101
2019
Q2
Sell
-48,215
Closed -$1.29M 1861
2019
Q1
$1.29M Sell
48,215
-1,646
-3% -$44.2K ﹤0.01% 1488
2018
Q4
$806K Buy
+49,861
New +$806K ﹤0.01% 1511
2018
Q2
Sell
-6,314
Closed -$142K 2078
2018
Q1
$142K Buy
+6,314
New +$142K ﹤0.01% 1926